Report on Igaas–Baghwal 2025 Celebration Initiative organised by SMS

Published on: November 1, 2025

Report on Igaas–Baghwal 2025 Celebration Initiative organised by SMS

The School of Management Studies (SMS), SRHU, organized the Igaas–Baghwal 2025 initiative titled “My Village, My Festival” from 01 to 12 November 2025. The activity aimed to celebrate Uttarakhand’s cultural heritage by inviting students, faculty, and staff to share short videos and photographs depicting traditional Igaas–Baghwal celebrations in their native villages. A total of 31 entries were submitted, out of which 13 videos were shortlisted based on authenticity and presentation quality. The top three were awarded First, Second, and Third Prizes, while the remaining ten shortlisted participants received Appreciation Certificates from the Hon’ble Vice Chancellor for their enthusiastic contributions. The Vice Chancellor appreciated the cultural richness reflected in the submissions and motivated participants to engage even more creatively in future editions. The event was efficiently coordinated by Mr. Shailendra Sainwal and Mr. Ankit Kukrety, with support from Dr. Som Aditya Juyal, Vice Principal, SMS. This initiative successfully strengthened cultural pride and community bonding within the SRHU family, with winning and shortlisted entries to be showcased on official social media platforms.

Screenshot 2025-11-27 140709

Screenshot 2025-11-27 140720

Screenshot 2025-11-27 140730

Screenshot 2025-11-27 140742

Admissions Form

Admission Open For 2025

×

International Endowed Chair Professor

Prof Rakesh Kumar

Prof Rakesh Kumar is the Founder and President of the Breast Cancer in Young Women Foundation (USA), dedicated to vaddressing the distinct issues affecting young women with breast cancer. He also serves as the International Endowed Chair Professor at the Cancer Research Institute of the Himalayan Institute of Medical Sciences. Additionally, he holds adjunct professorships at Rutgers New Jersey Medical School and Virginia Commonwealth University.

Dr Kumar earned his Ph.D. from the All India Institute of Medical Sciences in 1984 and began his research career at Memorial Sloan Kettering Cancer Center in January 1986. From 1988 to 2017, he held various academic and leadership positions —including faculty member, tenured professor, distinguished professor, endowed chair, department chair, and research leader—at esteemed institutions such as Memorial Sloan Kettering Cancer Center in New York and the University of Texas MD Anderson Cancer Center in Houston. From 2017 to 2022, he served as the National Chair for Cancer Research for the Government of India and as a distinguished professor, continuing his innovative work in breast cancer research.

With nearly 40 years of research and professional experience, Dr. Kumar has made conceptual contributions to the field of cancer research (h-index 108, citations >50,000). He has authored over 325 peer-reviewed publications, edited or co-edited nine books, and delivered 290 invited lectures worldwide. His work has been featured on the covers of 18 major cancer journals and has been highlighted in institutional research reports of the MD Anderson Cancer Center.

A passionate educator and mentor, Dr. Kumar has guided 67 trainees throughout his career. He serves on the editorial boards of multiple leading cancer journals and has served on the editorial boards of 21 top cancer journals. His global reputation is further demonstrated by his participation in about 100 peer-review panels for cancer research funding in the US and internationally over the past 28 years.

Dr. Kumar's innovative research has earned him numerous prestigious honors, including the Hinkle Society Faculty Award at Penn State University (1994), the Dalla/Fort Worth Living Legend Faculty Achievement Award in Basic Sciences (2004), the Ranbaxy Research Award (2006), and the Lifetime Achievement Award from the American Association of Indian Scientists in Cancer Research (2013), among others. Dr. Kumar's pioneering research continues to have a profound influence on the fields of oncology and breast cancer, opening up new opportunities for biomedical scientists and trainees worldwide.